Episode Details
Back to Episodes
Episode 499: APCCC 2026 - Radioligands
Published 5 months, 3 weeks ago
Description
This session from APCCC 2026 features expert Michael Morris discussing radioligand therapy, adaptive dosing, retreatment strategies, and the latest insights in current practices, challenges, and future directions in radiopharmaceuticals.